BIOY vs. FINY

Last updated Jul 21, 2026

BIOY (GraniteShares YieldBOOST Biotech ETF) and FINY (GraniteShares YieldBOOST Financials ETF) are both Derivative Income funds from GraniteShares. Both are actively managed. At a correlation of -0.09, they often move in opposite directions. Both charge a 1.07% expense ratio.

Performance

BIOY vs. FINY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GraniteShares YieldBOOST Biotech ETF (BIOY) and GraniteShares YieldBOOST Financials ETF (FINY). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

BIOY

• 1D: -3.35%
• 1M: -2.48%
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: —

FINY

• 1D: 0.12%
• 1M: 2.62%
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —
• ALL TIME*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BIOY vs. FINY - Yearly Performance Comparison

	2026 (YTD)
BIOY GraniteShares YieldBOOST Biotech ETF	-3.36%
FINY GraniteShares YieldBOOST Financials ETF	6.58%

Correlation

The correlation between BIOY and FINY is -0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (All Time) Calculated using the full available price history since May 5, 2026	-0.09

Return for Risk

BIOY vs. FINY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GraniteShares YieldBOOST Biotech ETF (BIOY) and GraniteShares YieldBOOST Financials ETF (FINY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Drawdowns

BIOY vs. FINY - Drawdown Comparison

The maximum BIOY drawdown since its inception was -6.64%, which is greater than FINY's maximum drawdown of -1.85%. Use the drawdown chart below to compare losses from any high point for BIOY and FINY.

Drawdown Indicators

	BIOY	FINY	Difference
Max Drawdown Largest peak-to-trough decline	-6.64%	-1.85%	-4.79%
Current Drawdown Current decline from peak	-6.64%	0.00%	-6.64%
Average Drawdown Average peak-to-trough decline	-2.16%	-0.10%	-2.06%

Volatility

Volatility by Period

	BIOY	FINY	Difference
Volatility (1Y) Calculated over the trailing 1-year period	18.55%	6.58%	+11.97%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	18.55%	6.58%	+11.97%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	18.55%	6.58%	+11.97%

BIOY vs. FINY - Expense Ratio Comparison

Both BIOY and FINY have an expense ratio of 1.07%.

Dividends

BIOY vs. FINY - Dividend Comparison

BIOY's dividend yield for the trailing twelve months is around 13.82%, more than FINY's 5.09% yield.

Position	TTM
BIOY GraniteShares YieldBOOST Biotech ETF	13.82%
FINY GraniteShares YieldBOOST Financials ETF	5.09%

Frequently Asked Questions

Can I hold both BIOY and FINY in my portfolio?

BIOY and FINY have a correlation of -0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, BIOY or FINY?

Both ETFs have the same 1.07% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, BIOY or FINY?

BIOY and FINY have the same expense ratio: 1.07% per year.

Which ETF pays a higher dividend yield, BIOY or FINY?

BIOY has the higher dividend yield at 13.82%, compared with 5.09% for FINY.